Late onset Wilson's disease: Therapeutic implications

Movement Disorders

Volumn 23, Issue 6, 2008, Pages 896-898

  Członkowska, Anna ^a,b   Rodo, Maria ^a   Gromadzka, Grazyna ^a,b  

^a INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Genotype; Late onset; Phenotype; Treatment; Wilson's disease

Indexed keywords

PENICILLAMINE; WILSON DISEASE PROTEIN; BIOLOGICAL MARKER; CERULOPLASMIN;

ADULT; AGED; ALBUMIN BLOOD LEVEL; APHASIA; ARTICLE; CASE REPORT; CERULOPLASMIN BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; COPPER URINE LEVEL; CORNEA DISEASE; DEPRESSION; ECHOGRAPHY; ENZYMATIC ASSAY; FAMILY; FAMILY HISTORY; FEMALE; GENETIC COUNSELING; HEMIPARESIS; HUMAN; JAUNDICE; KAYSER FLEISHER RING; LIVER DISEASE; MALE; MISSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PRIORITY JOURNAL; TRANSIENT ISCHEMIC ATTACK; TREMOR; URINE LEVEL; WILSON DISEASE; BLOOD; GENETICS; SIBLING;

AGE OF ONSET; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CERULOPLASMIN; FEMALE; HEPATOLENTICULAR DEGENERATION; HUMANS; MALE; SIBLINGS;

EID: 52449103827     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21985     Document Type: Article

References (17)

1. Ferenci P, Caca K, Loudianos G, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int 2003;23:139-142.
2. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007;369:397-408.
3. Członkowska A, Gajda J, Rodo M. Effects of long treatment in Wilson's disease with d-penicillamine and zinc sulphate. J Neurol 1996;243:269-273.
4. Walshe JM. Wilson's disease: The presenting symptoms. Arch Dis Child 1962;37:253-225.
5. Reddy K. Late onset Wilson disease frequently overlooked. Gastroenterology 2006;131:343.
6. Ferenci P, Czlonkowska A, Merle U, et al. Late-onset Wilson's disease. Gastroenterology 2007;132:1294-1298.
7. Sohtaoglu M, Ergin H, Ozekmekci S, Gokdemir S, Sonsuz A, Arici C. Patient with late-onset Wilson's disease: deterioration with penicillamine. Mov Disord 2007;22:290-291.
8. Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: raising the bar for diagnosis. Hepatology 2005;41:668-670.
9. Walshe JM, Waldenstrom E, Sams V, Nordlinder H, Westermark K. Abdominal malignancies in patients with Wilson's disease. Q J Med 2003;96:657-662.
10. Czlonkowska A, Rodo M. Late onset of Wilson's disease. Report of family. Arch Neurol 1981;38:729-730.
11. Ravin HA. An improved colorimetric assay of ceruloplasmin. J Lab Clin Med 1961;61:161-168.
12. Fitzgerald MA, Gross JB, Goldstein NP, Wahner HW, McCall JT. Wilson's disease (hepatolenticular degeneration) of late adult onset: report of case. Mayo Clin Proc 1975;50:438-442.
13. Ross ME, Jacobson IM, Dienstag JL, Martin JB. Late-onset Wilson's disease with neurological involvement in the absence of Kayser-Fleischer rings. Ann Neurol 1985;17:411-413.
14. Danks DM, Metz G, Sewell R, Prewett EJ. Wilson's disease in adults with cirrhosis but no neurological abnormalities. BMJ 1990;301:331-332.
15. Gromadzka G, Schmidt HH, Genschel J, et al. p.H1069Q mutation in ATP7B and biochemical parameters of copper metabolism and clinical manifestation of Wilson's disease. Mov Disord 2006;21:245-248.
16. Gromadzka G, Schmidt HH, Genschel J, et al. Frameshift and nonsense mutations in the gene for ATPase7B are associated with severe impairment of copper metabolism and with an early clinical manifestation of Wilson's disease. Clin Genet 2005;68: 524-532.
17. Lutsenko S, Barnes NL, Bartee MY, Dmitriev OY. Function and regulation of human copper-transporting ATPases. Physiol Rev 2007;87:1011-1046.